Navigation Links
AVN944 in Medical Technology

Avalon Updates the AVN944 Phase I Hematologic Malignancies Trial

GERMANTOWN, Md., June 13, 2007 /PRNewswire-FirstCall/ -- Avalon Pharmaceuticals, Inc. , today announced that it is will provide an update on the Phase I clinical trial of AVN944 in hematologic malignancies on Tuesday, June 19, 2007, after the close of the U.S. financial markets. The Company will a...

Avalon Pharmaceuticals to Present at the American Association for Cancer Research 2007 Annual Meeting

...valon Pharmaceuticals, Inc. , today announced that avn944 will be the subject of three poster presentations ...and in vivo experiments that reveal the effects of avn944 on blood vessel formation. The presentation will b...acific Time. Another poster that will discuss avn944 will be presented by the lab of Dr. Beverly Mitche...

Avalon Pharmaceuticals Announces Positive Interim Results For AVN944 Phase I Trial

...rly and refractory patients. Interim data indicate avn944 is well tolerated, has dose-dependent pharmacokine...ncouraged by the positive interim results from the avn944 trial," stated Michael Hamilton, M.D., Avalon Phar...tiate multiple Phase II studies." Background: avn944 is an oral small molecule drug that inhibits inosi...
AVN944 in other areas

Avalon Pharmaceuticals Initiates AVN944 Phase I Clinical Trial in ...

We believe that AVN944 has the potential to offer oncologists and cancer patients ... of the safety and tolerability of AVN944 in adult patients with advanced ...

Microsoft Word - 090705_Avalon

Drug Administration (FDA) for their lead candidate, AVN944 for treatment of cancer. ... AVN944 is an inhibitor of the enzyme inosine monophosphate ...

Avalon Updates The AVN944 Phase I Hematologic Malignancies Trial

Avalon Pharmaceuticals, Inc. (Nasdaq: AVRX), today announced that it is will provide an update on the Phase I clinical trial of AVN944 in hematologic malignancies on ...

FOR IMMEDIATE RELEASE Contacts: Avalon Pharmaceuticals, Inc. Noonan ...

AVN944 is an orally bioavailable inhibitor of inosine monophosphate dehydrogenase 1 and 2 ... of sensitivity and resistance to AVN944 ... benefit from AVN944. ...

Avalon Pharmaceuticals Announces the Activation of IND for AVN944 for ...

AVN944 is an oral, small molecule inhibitor of the enzyme inosine monophosphate ... AVN944 was in-licensed by Avalon from Vertex Pharmaceuticals Incorporated ...

Summary of AVALON PHARMACEUTICALS INC - Yahoo! Finance

... therapeutics, and the in-license and development of AVN944. ... AVN944 was in-licensed by us from Vertex in February 2005. Financial Operations Overview ...
Other Tags
(Date:7/28/2015)... ... 28, 2015 , ... Today, enterprise request management (ERM) and ... upgrade and expansion of its ERM system using Kinetic Data software. ... 134 countries supplying a wide range of business and residential energy products and ...
(Date:7/28/2015)... ... July 28, 2015 , ... BiologicsMD, ... combination products for the treatment of bone disorders and conditions of hair loss, ... entitled "Fusion Proteins of Collagen Binding-Domain and Parathyroid Hormone". The issued patent claims ...
(Date:7/28/2015)... ... July 28, 2015 , ... A new ... workers than they are in the general population. Surviving Mesothelioma has just posted ... , Researchers at Taiwan’s National Health Research Institutes and three Taiwanese universities ...
(Date:7/28/2015)... ... ... Women fear developing Alzheimer's disease more than having a heart attack or stroke ... but there is little an individual can do to arrest the progress of Alzheimer's ... reports the July 2015 Harvard Women's Health Watch . , "There are now ...
(Date:7/28/2015)... ... ... Every summer, the public is reminded to leave the Fourth of July ... own neighborhoods. Unfortunately, according to a recent report issued by the U.S. Consumer Product ... Eye Injuries Caused by Fireworks Doubled in Last 3 Years ," the number of ...
Breaking Medicine News(10 mins):Health News:Schneider Electric Amps Up Its Use of Kinetic Data’s Enterprise Request Management Software 2Health News:Schneider Electric Amps Up Its Use of Kinetic Data’s Enterprise Request Management Software 3Health News:Schneider Electric Amps Up Its Use of Kinetic Data’s Enterprise Request Management Software 4Health News:BiologicsMD, Inc. Announces Additional US Patent Issuance Covering Company’s Pipeline of Targeted Therapies 2Health News:New Findings Suggest Mesothelioma is Not the Only Cancer Threat for Shipbreakers, According to Surviving Mesothelioma 2Health News:Fight Alzheimer's By Taking Part in a Clinical Trial, From the July 2015 Harvard Women's Health Watch 2Health News:Fight Alzheimer's By Taking Part in a Clinical Trial, From the July 2015 Harvard Women's Health Watch 3Health News:Carlsbad Ophthalmologist Discusses Doubling of Fireworks Eye Injuries in Three Year Span 2Health News:Carlsbad Ophthalmologist Discusses Doubling of Fireworks Eye Injuries in Three Year Span 3
(Date:6/24/2015)... 24, 2015 The biologics safety testing market ... for the market include growth of the pharmaceutical and ... launches. Over the years, the number of drug approvals ... 2010, the FDA approved 225 drug applications and Health ... Europe accounted for 3,822 of the ...
(Date:6/24/2015)... SAN JOSE, Calif. , June 24, 2015 ... leading developer of human interface solutions, today announced ... fingerprint sensor to provide secure authentication for its ... Having recently reached more than 200 million shipments ... shipment with Sharp reinforces Synaptics, strength, scalability and ...
(Date:6/24/2015)... Switzerland , June 24, 2015 ... partnership with emerging biometric password solution one face ... one face in, entering ... a ground-breaking and affordable multifactor-authentication biometric answer to ... recognition technology, provided in partnership with KeyLemon, one ...
Breaking Biology News(10 mins):Biological Safety Testing Market by Application, Product, & Test - Global Forecast to 2019 2Biological Safety Testing Market by Application, Product, & Test - Global Forecast to 2019 3Biological Safety Testing Market by Application, Product, & Test - Global Forecast to 2019 4Synaptics Brings Natural ID Technology to Sharp's Newest Flagship Smartphone 2KeyLemon Announces Partnership With Biometric Password Solution onefacein 2
Other Contents